KARAHALİL, B. Et Al. 2022. Metabolomics mapping changed after olanzapine therapy in drug-naive schizophrenia patients-the significant impact of gene polymorphisms. TOXICOLOGY RESEARCH , vol.11 , 547-556.

KARAHALİL, B., ELKAMA, A., AK, M., & NEMUTLU, E., (2022). Metabolomics mapping changed after olanzapine therapy in drug-naive schizophrenia patients-the significant impact of gene polymorphisms. TOXICOLOGY RESEARCH , vol.11, 547-556.

KARAHALİL, BENSU Et Al. "Metabolomics mapping changed after olanzapine therapy in drug-naive schizophrenia patients-the significant impact of gene polymorphisms," TOXICOLOGY RESEARCH , vol.11, 547-556, 2022

KARAHALİL, BENSU Et Al. "Metabolomics mapping changed after olanzapine therapy in drug-naive schizophrenia patients-the significant impact of gene polymorphisms." TOXICOLOGY RESEARCH , vol.11, pp.547-556, 2022

KARAHALİL, B. Et Al. (2022) . "Metabolomics mapping changed after olanzapine therapy in drug-naive schizophrenia patients-the significant impact of gene polymorphisms." TOXICOLOGY RESEARCH , vol.11, pp.547-556.

@article{article, author={BENSU KARAHALİL Et Al. }, title={Metabolomics mapping changed after olanzapine therapy in drug-naive schizophrenia patients-the significant impact of gene polymorphisms}, journal={TOXICOLOGY RESEARCH}, year=2022, pages={547-556} }